The roles of ubiquitin modifying enzymes in neoplastic disease
MetadataShow full item record
© 2017 Elsevier B.V. The initial experiments performed by Rose, Hershko, and Ciechanover describing the identification of a specific degradation signal in short-lived proteins paved the way to the discovery of the ubiquitin mediated regulation of numerous physiological functions required for cellular homeostasis. Since their discovery of ubiquitin and ubiquitin function over 30 years ago it has become wholly apparent that ubiquitin and their respective ubiquitin modifying enzymes are key players in tumorigenesis. The human genome encodes approximately 600 putative E3 ligases and 80 deubiquitinating enzymes and in the majority of cases these enzymes exhibit specificity in sustaining either pro-tumorigenic or tumour repressive responses. In this review, we highlight the known oncogenic and tumour suppressive effects of ubiquitin modifying enzymes in cancer relevant pathways with specific focus on PI3K, MAPK, TGFß, WNT, and YAP pathways. Moreover, we discuss the capacity of targeting DUBs as a novel anticancer therapeutic strategy.
Showing items related by title, author, creator and subject.
MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/ T-cell lymphomaLi, B.; Yan, J.; Phyu, T.; Fan, S.; Chung, T.H.; Mustafa, N.; Lin, B.; Wang, L.; Eichhorn, Pieter; Goh, B.C.; Ng, S.B.; Kappei, D.; Chng, W.J. (2019)© 2019 by The American Society of Hematology Oncogenic EZH2 is overexpressed and extensively involved in the pathophysiology of different cancers including extranodal natural killer/T-cell lymphoma (NKTL). However, the ...
Iyengar, P.; Jaynes, P.; Rodon, L.; Lama, D.; Law, K.; Lim, Y.; Verma, C.; Seoane, J.; Eichhorn, Pieter (2015)Ubiquitin modification of the TGF-ß pathway components is emerging as a key mechanism of TGF-ß pathway regulation. To limit TGF-ß responses, TGF-ß signaling is regulated through a negative feedback loop whereby the E3 ...
Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnoverNguyen, H.; Andrejeva, D.; Gupta, R.; Choudhary, C.; Hong, X.; Eichhorn, Pieter; Loya, A.; Cohen, S. (2016)The Hippo pathway has been identified as a key barrier for tumorigenesis, acting through downregulation of YAP/TAZ activity. Elevated YAP/TAZ activity has been documented in many human cancers. Ubiquitylation has been ...